首页> 外文期刊>Pharmaceutical statistics. >A Bayesian approach to sequential analysis in post‐licensure vaccine safety surveillance
【24h】

A Bayesian approach to sequential analysis in post‐licensure vaccine safety surveillance

机译:发牌后疫苗安全监测中顺序分析的贝叶斯方法

获取原文
获取原文并翻译 | 示例
       

摘要

With rapid development of computing technology, Bayesian statistics have increasingly gained more attention in various areas of public health. However, the full potential of Bayesian sequential methods applied to vaccine safety surveillance has not yet been realized, despite acknowledged practical benefits and philosophical advantages of Bayesian statistics. In this paper, we describe how sequential analysis can be performed in a Bayesian paradigm in the field of vaccine safety. We compared the performance of the frequentist sequential method, specifically, Maximized Sequential Probability Ratio Test (MaxSPRT), and a Bayesian sequential method using simulations and a real world vaccine safety example. The performance is evaluated using three metrics: false positive rate, false negative rate, and average earliest time to signal. Depending on the background rate of adverse events, the Bayesian sequential method could significantly improve the false negative rate and decrease the earliest time to signal. We consider the proposed Bayesian sequential approach to be a promising alternative for vaccine safety surveillance.
机译:随着计算技术的快速发展,贝叶斯统计在公共卫生的各个领域越来越受到重视。然而,贝叶斯序贯方法应用于疫苗安全监测的全部潜力尚未实现,尽管贝叶斯统计具有公认的实际益处和哲学优势。在本文中,我们描述了如何在疫苗安全领域的贝叶斯范式中进行序列分析。我们使用模拟和现实世界的疫苗安全性示例,比较了频率序列方法,特别是最大序列概率比测试(MaxSPRT)和贝叶斯序列方法的性能。使用三个指标评估性能:假阳性率、假阴性率和平均最早发出信号的时间。根据不良事件的背景发生率,贝叶斯序贯方法可以显著提高假阴性率,并缩短发出信号的最早时间。我们认为所提出的贝叶斯序贯方法是一种有前途的替代疫苗安全监测。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号